Yen-Fang Keng
Directeur Technique/Scientifique/R&D chez X-Cell Medical, Inc.
Postes actifs de Yen-Fang Keng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
X-Cell Medical, Inc.
 X-Cell Medical, Inc. Medical SpecialtiesHealth Technology X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Yen-Fang Keng
Anciens postes connus de Yen-Fang Keng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Morphochem, Inc.
 Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Morphochem, Inc. manufactures and develops drugs. It uses proprietary whole-cell high throughput screening systems to discover novel compounds of therapeutic value for disorders including cancer & immunological, infectious & metabolic diseases, and for applications in agriculture. The company was founded by Prabhavathi Fernandes in 1997 and is located in Monmouth Junction, NJ | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
X-Cell Medical, Inc.
X-Cell Medical, Inc. Medical SpecialtiesHealth Technology X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ. | Health Technology |
Morphochem, Inc.
Morphochem, Inc. Pharmaceuticals: MajorHealth Technology Morphochem, Inc. manufactures and develops drugs. It uses proprietary whole-cell high throughput screening systems to discover novel compounds of therapeutic value for disorders including cancer & immunological, infectious & metabolic diseases, and for applications in agriculture. The company was founded by Prabhavathi Fernandes in 1997 and is located in Monmouth Junction, NJ | Health Technology |
- Bourse
- Insiders
- Yen-Fang Keng
- Expérience
